Recursion Pharmaceuticals › Many investors seek to capitalize on the rapidly growing artificial intelligence (AI) industry.

Detailed information on Laaman's latest Recursion take weren't immediately available. Image source: . They weren't all that ...

It offered multiple conflicting reasons for its absence, some of which were controversial enough that NBC reporters wrote ...